SMI481
CAS No. 432020-20-7
SMI481 ( SMI-481 SMI 481; NPPM 6748-481; NPPM 6748481; NPPM6748481; NPPM-6748-481 )
Catalog No. M27830 CAS No. 432020-20-7
SMI481 is the first small-molecule Sec14-like phosphatidylinositol transfer proteins (PITPs) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | Get Quote |
|
10MG | 58 | Get Quote |
|
25MG | 88 | Get Quote |
|
50MG | 140 | Get Quote |
|
100MG | 205 | Get Quote |
|
500MG | 516 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSMI481
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMI481 is the first small-molecule Sec14-like phosphatidylinositol transfer proteins (PITPs) inhibitor.
-
DescriptionSMI481 is the first small-molecule Sec14-like phosphatidylinositol transfer proteins (PITPs) inhibitor.(In Vitro):Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs nor PITPs in general have been exploited as targets for chemical inhibition for such purposes. Herein, we validate what is to our knowledge the first small-molecule inhibitors (SMIs) of the yeast PITP Sec14. These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs) and are effective inhibitors in vitro and in vivo. We further establish that Sec14 is the sole essential NPPM target in yeast and that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects and demonstrate that NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling in cells. These data deliver proof of concept that PITP-directed SMIs offer new and generally applicable avenues for intervening with phosphoinositide signaling pathways with selectivities superior to those afforded by contemporary lipid kinase-directed strategies.
-
SynonymsSMI-481 SMI 481; NPPM 6748-481; NPPM 6748481; NPPM6748481; NPPM-6748-481
-
PathwayOthers
-
TargetOther Targets
-
RecptorPAR-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number432020-20-7
-
Formula Weight363.8
-
Molecular FormulaC17H15ClFN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[O-][N+](=O)c1cc(ccc1Cl)C(=O)N1CCN(CC1)c1ccccc1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ibrahim Sulaiman, et al. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation. Pulm Pharmacol Ther. 2016 Oct;40:52-68.
molnova catalog
related products
-
Adamantanine
Adamantanine is an amino acid transport inhibitor.
-
BC-DXI-843
BC-DXI-843 is inhibitor of AIMP2-DX2, and is potential for development of novel therapeutics targeting AIMP2-DX2 in lung cancer.
-
Uprosertib
Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.